Imagion Biosystems Ltd.ASX: IBX

Imagion Initiates Manufacturing of Drug for Phase 2 Study

· Issued by Imagion Biosystems Ltd.

Filed with ASX · · 2 pages · English

Summary by 6ix AI

This manufacturing is a key step towards filing an Investigational New Drug application with the US FDA. The company aims to optimize the imaging agent's dose and protocol to enhance diagnostic performance during the study.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Imagion Biosystems Ltd. on 6ix

Earlier from Imagion Biosystems

Later from Imagion Biosystems

All Imagion Biosystems news releases